Renin-angiotensin-aldosterone system blockers and cardiovascular outcomes: a meta-analysis of randomized clinical trials

Renin-angiotensin-aldosterone system blockers and cardiovascular outcomes: a meta-analysis of randomized clinical trials

Objective: Hypertension is the most prevalent modifiable risk factor for cardiovascular (CV) and cerebrovascular morbidity and mortality. This study aimed to assess the effects of renin-angiotensin-aldosterone system (RAAS) blockade on CV outcomes. Methods: This study was designed according to the...

Full description

Bibliographic Details
Main Authors: Pınar Kızılırmak, Yağız Üresin, Oktay Özdemir, Burçak Kılıçkıran Avcı, Lale Tokgözoğlu, Zeki Öngen
Format: Article
Language:English
Published: KARE Publishing 2017-01-01
Series:Türk Kardiyoloji Derneği Arşivi
Subjects:
ace inhibitors
angiotensin receptor blocker
antihypertensive therapy
hypertension-vascular disease; outcomes of care.
Online Access:https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tkd&un=TKDA-78006

Internet

https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tkd&un=TKDA-78006

Similar Items